THER-03. REPURPOSING MEFLOQUINE AND ANALOGUES FOR DIPG THERAPY

Por Teng, Jian, Tannous, Bakhos
Publicado no Neuro Oncol (2019)

THER-10. TELOMERE TARGETING BASED-THERAPIES TO TREAT THERAPY-RESISTANT PEDIATRIC BRAIN TUMORS

Por Sengupta, Satarupa, Kumar, Shiva Senthil, Mishra, Deepak, Drissi, Rachid
Publicado no Neuro Oncol (2019)

Beyond the Cholinergic Hypothesis: Do Current Drugs Work in Alzheimer's Disease?

Por Martorana, Alessandro, Esposito, Zaira, Koch, Giacomo
Publicado no CNS Neurosci Ther (2010)

Heterogeneity of Alzheimer’s disease: consequence for drug trials?

Por Devi, Gayatri, Scheltens, Philip
Publicado no Alzheimers Res Ther (2018)

Penehyclidine hydrochloride: a potential drug for treating COPD by attenuating Toll-like receptors

Por Xiao, Hong-Tao, Liao, Zhi, Tong, Rong-Sheng
Publicado em 2012

Sulforaphane Increases Drug-mediated Cytotoxicity Toward Cancer Stem-like Cells of Pancreas and Prostate

Por Kallifatidis, Georgios, Labsch, Sabrina, Rausch, Vanessa, Mattern, Juergen, Gladkich, Jury, Moldenhauer, Gerhard, Büchler, Markus W., Salnikov, Alexei V., Herr, Ingrid
Publicado em 2011

Toll-like receptors as therapeutic targets for autoimmune connective tissue diseases

Por Li, Jing, Wang, Xiaohui, Zhang, Fengchun, Yin, Hang
Publicado em 2013

Toll-like receptors in the pathogenesis of autoimmune diseases: recent and emerging translational developments

Por Duffy, Laura, O’Reilly, Steven C
Publicado no Immunotargets Ther (2016)

Diabetes and cardiovascular disease: focus on glucagon-like peptide-1 based therapies

Por Stranges, Paul, Khanderia, Ujjaini
Publicado em 2012

Design, development, drug-likeness, and molecular docking studies of novel piperidin-4-imine derivatives as antitubercular agents

Por Revathi, Rajappan, Venkatesha Perumal, Ramachandran, Pai, Karkala Sreedhara Ranganath, Arunkumar, Govindakarnavar, Sriram, Dharmarajan, Kini, Suvarna Ganesh
Publicado no Drug Des Devel Ther (2015)

Off‐label prescriptions of drugs used for the treatment of Crohn’s disease or ulcerative colitis

Por Simsek, Melek, Lissenberg‐Witte, Birgit I., van Riswijk, Milou L. M., Verschuren, Sander, Hoentjen, Frank, Oldenburg, Bas, Ponsioen, Cyriel Y., van der Woude, C. Janneke, van der Meulen, Andrea E., Pierik, Marieke, Dijkstra, Gerard, de Boer, Nanne K. H.
Publicado no Aliment Pharmacol Ther (2019)

Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer disease

Por Zetterberg, Henrik, Mattsson, Niklas, Blennow, Kaj, Olsson, Bob
Publicado em 2010

A novel Alzheimer’s disease drug candidate targeting inflammation and fatty acid metabolism

Por Daugherty, Daniel, Goldberg, Joshua, Fischer, Wolfgang, Dargusch, Richard, Maher, Pamela, Schubert, David
Publicado no Alzheimers Res Ther (2017)

Analysis of West Virginia medicaid claims data for the prevalence of medical conditions and use of drugs likely to cause QT prolongation in patients with schizophrenia()

Por Kalsekar, Iftekhar D, Makela, Eugene H, Moeller, Karen E
Publicado em 2003

Drug-induced Rowell syndrome, a rare and difficult to manage disease: A case report

Por Brănișteanu, Daciana Elena, Ianoşi, Simona Laura, Dimitriu, Andreea, Stoleriu, Gabriela, Oanţǎ, Alexandru, Brănișteanu, Daniel Constantin
Publicado no Exp Ther Med (2018)

Patient preferences for disease-modifying drugs in multiple sclerosis therapy: a choice-based conjoint analysis

Por Utz, Kathrin S., Hoog, Jana, Wentrup, Andreas, Berg, Sebastian, Lämmer, Alexandra, Jainsch, Britta, Waschbisch, Anne, Lee, De-Hyung, Linker, Ralf A., Schenk, Thomas
Publicado no Ther Adv Neurol Disord (2014)

Factors associated with initial or subsequent choice of biologic disease-modifying antirheumatic drugs for treatment of rheumatoid arthritis

Por Jin, Yinzhu, Desai, Rishi J., Liu, Jun, Choi, Nam-Kyong, Kim, Seoyoung C.
Publicado no Arthritis Res Ther (2017)

Lactobacilli with superoxide dismutase-like or catalase activity are more effective in alleviating inflammation in an inflammatory bowel disease mouse model

Por Tomusiak-Plebanek, Anna, Heczko, Piotr, Skowron, Beata, Baranowska, Agnieszka, Okoń, Krzysztof, Thor, Piotr J, Strus, Magdalena
Publicado no Drug Des Devel Ther (2018)

Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides

Por Bonaci-Nikolic, Branka, Nikolic, Milos M, Andrejevic, Sladjana, Zoric, Svetlana, Bukilica, Mirjana
Publicado em 2005

The Metabotropic Glutamate Receptor 4-Positive Allosteric Modulator VU0364770 Produces Efficacy Alone and in Combination with l-DOPA or an Adenosine 2A Antagonist in Preclinical Rodent Models of Parkinson's Disease

Por Jones, Carrie K., Bubser, Michael, Thompson, Analisa D., Dickerson, Jonathan W., Turle-Lorenzo, Nathalie, Amalric, Marianne, Blobaum, Anna L., Bridges, Thomas M., Morrison, Ryan D., Jadhav, Satyawan, Engers, Darren W., Italiano, Kimberly, Bode, Jacob, Daniels, J. Scott, Lindsley, Craig W., Hopkins, Corey R., Conn, P. Jeffrey, Niswender, Colleen M.
Publicado em 2012